Insulin prices have skyrocketed over the last few decades, making diabetes one of the more expensive diseases to manage. Families struggled and often underdosed themselves just so they would not run out of medicine. Rodica Pop-Busui, M.D., Ph.D., Larry D. Soderquist, professor of diabetes and associate director for clinical research, discusses the newly adopted price cap for insulin and its implications.
